Effect of 2nd Gen TKI in CML

CompletedOBSERVATIONAL
Enrollment

432

Participants

Timeline

Start Date

January 1, 2010

Primary Completion Date

March 19, 2014

Study Completion Date

September 29, 2017

Conditions
Myeloid Leukemia, Chronic
Trial Locations (10)

Unknown

Rigshospitalet, Copenhagen

Helsinki University Central Hospital, Helsinki

University of Freiburg, Freiburg im Breisgau

University of Muenster, Münster

St Ivan & St Laszlo Hospital, Budapest

Chaim Sheba Medical Centre, Tel Litwinsky

Medical University of Silesia, Katowice

St Petersburg State Medical Pavlov University, Saint Petersburg

King Faisal Specialist Hospital & Research Centre, Riyadh

Hammersmith, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

European Society for Blood and Marrow Transplantation

NETWORK

NCT02222272 - Effect of 2nd Gen TKI in CML | Biotech Hunter | Biotech Hunter